BioPharmSignal logoBioPharmSignal

Biotech News

GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale

GoodRx (GDRX)GoodRxCompany update

Independent assessment validates GoodRx’s continued leadership in cybersecurity and data protection SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 2, 2026-- GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced it has earned its 2026 certification status

Related news

GDRXGoodRx2026-05-27 13:00 EST

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

GDRXGoodRx2026-07-09 20:05 EST

GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call

View all latest news

GoodRx

Medication-Savings Platform GoodRx is a U.S. digital platform that helps consumers compare prescription prices and access discounts at pharmacies. Consumer and Provider Network The service connects consumers, pharmacies, pharmacy-benefit managers, manufacturers and healthcare professionals. Users access savings through the website,...

Recent company news

GDRXGoodRx2026-08-05 20:05 EST

GoodRx Reports Second Quarter 2026 Results

GDRXGoodRx2026-07-09 20:05 EST

GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call

GDRXGoodRx2026-05-27 13:00 EST

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

GDRXGoodRx2026-05-06 20:05 EST

GoodRx Reports First Quarter 2026 Results

GDRXGoodRx2026-05-01 12:10 EST

GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients

Stock data

Close
3.72 USD
Market cap
999.09M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States